Bronchiectasis: Clinical Trials

13 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 13
Phase 25Completed 5

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
RCT1100 - Primary Ciliary Dyskinesia (PCD)
Phase 1CompletedReCode Therapeutics142024-10-222026-04-30
A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD
RCT1100 - Primary Ciliary Dyskinesia
Phase 1CompletedReCode Therapeutics72024-09-202025-10-08
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis
CHF6333, CHF6333 Placebo - Bronchiectasis
Phase 1 / Phase 2CompletedChiesi Farmaceutici S.p.A.1082023-11-292026-10-26
Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects
RCT1100 - Primary Ciliary Dyskinesia
Phase 1CompletedReCode Therapeutics92023-02-182025-04-29
Autologous Transplantation of Bronchial Basal Cells for Treatment of Bronchiectasis
Bronchial basal cells (BBCs), Bronchoscopic airway clearance treatment (B-ACT) - Bronchiectasis
Phase 1 / Phase 2CompletedRuijin Hospital372020-06-212023-12-05
Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis
hMSCs - Bronchiectasis
Phase 1CompletedMarilyn Glassberg62016-02-042019-08-28
Inhalation Flow Rate-study
T-326 Inhaler - Bronchiectasis
Phase 1CompletedBayer332015-11-232017-04-26
Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
Molgramostim, Placebo - Pulmonary Alveolar Proteinosis, Bronchiectasis
Phase 1CompletedSavara Inc.422015-05-012017-02-23
Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
Tobramycin - Bronchiectasis
Phase 1 / Phase 2CompletedUniversity Medical Center Groningen82013-10-012014-12-16
A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
DAS181 dry powder, formulation F02, Respitose ML006 (DMV-Fonterra) - Asthma, Bronchiectasis
Phase 1CompletedAnsun Biopharma, Inc.112010-07-012019-03-27
Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis
Exercise - Bronchiectasis
Phase 1CompletedBayside Health392009-02-012014-03-11
High Dose Inhaled Mannitol Study
mannitol - Bronchiectasis
Phase 1 / Phase 2CompletedSyntara102009-01-012010-02-26
A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
dry powder inhaled mannitol - Healthy, Bronchiectasis
Phase 1 / Phase 2CompletedSyntara152008-08-012009-09-18

Narrower conditions

Ciliary Motility Disorders (3)  ·  Kartagener Syndrome (3)  ·  Asthma (1)  ·  Cystic Fibrosis (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Alveolar Proteinosis (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Bronchial Diseases (13)  ·  Respiratory Tract Diseases (13)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Abnormalities, Multiple (3)  ·  Cardiovascular Abnormalities (3)  ·  Cardiovascular Diseases (3)  ·  Ciliopathies (3)  ·  Congenital Abnormalities (3)  ·  Dextrocardia (3)  ·  Heart Defects, Congenital (3)  ·  Heart Diseases (3)  ·  Lung Diseases (3)  ·  Otorhinolaryngologic Diseases (3)

Interventions

Colony-Stimulating Factors (1)  ·  Exercise (1)  ·  Mannitol (1)  ·  Tobramycin (1)  ·  molgramostim (1)  ·  regramostim (1)

Sponsors

ReCode Therapeutics (3)  ·  Syntara (2)  ·  Ansun Biopharma, Inc. (1)  ·  Bayer (1)  ·  Bayside Health (1)  ·  Chiesi Farmaceutici S.p.A. (1)  ·  Marilyn Glassberg (1)  ·  Ruijin Hospital (1)  ·  Savara Inc. (1)  ·  University Medical Center Groningen (1)

Countries

Australia (4)  ·  United Kingdom (4)  ·  United States (4)  ·  Germany (2)  ·  China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  New Zealand (1)

Top investigators

John Matthews, MBBS, MCRP, PhD (3)  ·  Annemarie L Lee, PhD (1)  ·  Glassberg K Marilyn, MD (1)  ·  Heymut Omran, MD (1)  ·  Huib Kerstjens, MD, PhD (1)  ·  James D. Chalmers (1)  ·  Johnston Steward, MD (1)  ·  Kenneth Olivier, MD, MPH, LCID, NIAID (1)  ·  Kim G Nielsen, Dr Med Sci (1)  ·  Michael Loebinger, MD (1)  ·  Ronald Moss, MD (1)  ·  Yun Feng, M.D., Ph.D (1)

Results publications

PMID 20122281, PMID 24731015, PMID 26252343, PMID 26830468, PMID 28193704, PMID 30848695, PMID 39566467, PMID 40973220